The U.S. Food and Drug Administration late Thursday approved a new kind of drug to treat schizophrenia, a breakthrough after 70 years of incremental innovation that appears to avoid side effects ...

While antipsychotics can be effective for some patients, they come with well-known side effects, including an increased risk ...

Peptide antigen-associated IgG levels were significantly lower in drug-naïve patients with first episode psychosis compared to control individuals.

Researchers from the National Healthcare Group (NHG)'s Institute of Mental Health (IMH) and Agency for Science, Technology ...

A new study conducted by researchers at the University ... It found that residents who were given antipsychotic medications showed a significant worsening of their behaviors.

A new study by researchers at the University of Waterloo demonstrates that antipsychotic medications significantly worsened behavior in nursing home residents. “The proportion of long-term care ...

The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.

Purpose: The association of antipsychotic and antidepressant drugs with Q-T interval prolongation is reviewed. Summary: Prolongation of the Q-T interval can be of particular concern to ...

CMS has released its official 2025 mission and priorities document outlining its roadmap for state survey agencies Monday.

Dr. Jo Howe and Professor Ian Maidment from Aston Pharmacy School have won funding for a new project to develop new ways to ...